Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
Molecules · 27.02.2023 · 28 (5) · 2195
DOI: 10.3390/molecules28052195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 27.02.2023. Verfasst von Songtao Gu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory & Critical Care Medicine, Tianjin Chest Hospital, No. 261 Taierzhuang South Road, Jinnan District, Tianjin 300222, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Foundation of Organ Fibrosis Druggability Joint Research Centre of Nankai and Guokaixingcheng.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with unknown etiology, high mortality and limited treatment options. It is characterized by myofibroblast proliferation and extensive deposition of extracellular matrix (ECM), which will lead to fibrous proliferation and the destruction of lung structure. Transforming growth factor-β1 (TGF-β1) is widely recognized as a central pathway of pulmonary fibrosis, and the suppression of TGF-β1 or the TGF-β1-regulated signaling pathway may thus offer potential antifibrotic therapies. JAK-STAT is a downstream signaling pathway regulated by TGF-β1. JAK1/2 inhibitor baricitinib is a marketed drug for the treatment of rheumatoid arthritis, but its role in pulmonary fibrosis has not been reported. This study explored the potential effect and mechanism of baricitinib on pulmonary fibrosis in vivo and in vitro. The in vivo studies have shown that baricitinib can effectively attenuate bleomycin (BLM)-induced pulmonary fibrosis, and in vitro studies showed that baricitinib attenuates TGF-β1-induced fibroblast activation and epithelial cell injury by inhibiting TGF-β1/non-Smad and TGF-β1/JAK/STAT signaling pathways, respectively. In conclusion, baricitinib, a JAK1/2 inhibitor, impedes myofibroblast activation and epithelial injury via targeting the TGF-β1 signaling pathway and reduces BLM-induced pulmonary fibrosis in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory & Critical Care Medicine, Tianjin Chest Hospital, No. 261 Taierzhuang South Road, Jinnan District, Tianjin 300222, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300353, China.
- Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin 300457, China.
- Tianjin Jikun Technology Co., Ltd., Tianjin 301700, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Foundation of Organ Fibrosis Druggability Joint Research Centre of Nankai and Guokaixingcheng
- Fundamental Research Funds for the Central Universities, Nankai University
Zitieren
APA
Gu, S., Liang, J., Zhang, J., Liu, Z., Miao, Y., Wei, Y., Li, S., Gu, J., Cui, Y., Xiao, T., Li, X., & Yang, C. (2023). Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway. Molecules, 28(5), 2195. https://doi.org/10.3390/molecules28052195
Vancouver
Gu S, Liang J, Zhang J, Liu Z, Miao Y, Wei Y, et al. Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway. Molecules. 2023;28(5):2195. doi:10.3390/molecules28052195
BibTeX
@article{Gu2023,
author = {Gu, Songtao and Liang, Jingjing and Zhang, Jianwei and Liu, Zhichao and Miao, Yang and Wei, Yuli and Li, Shimeng and Gu, Jinying and Cui, Yunyao and Xiao, Ting and Li, Xiaohe and Yang, Cheng},
title = {Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway},
journal = {Molecules},
year = {2023},
volume = {28},
number = {5},
pages = {2195},
doi = {10.3390/molecules28052195}
}
EUVIMED